Friday, July 15, 2016, 37 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $87.69 to $104,800,000.00.

Highlighted Stocks Traded by Insiders:

Perry Ellis International (PERY) - FREE Research Report

Feldenkreis George, who is Executive Chairman at Perry Ellis International, sold 20,000 shares at $22.05 on July 15, 2016. Following this transaction, the Executive Chairman owned 1.7 million shares meaning that the stake was reduced by 1.18% with the 20,000-share transaction.

The shares most recently traded at $22.04, down $0.01, or 0.03% since the insider transaction. Historical insider transactions for Perry Ellis International go as follows:

  • 4-Week # shares sold: 3,859
  • 12-Week # shares sold: 3,859
  • 24-Week # shares sold: 3,859

The average volume for Perry Ellis International has been 88,500 shares per day over the past 30 days. Perry Ellis International has a market cap of $342.0 million and is part of the consumer goods sector and consumer non-durables industry. Shares are up 19.27% year-to-date as of the close of trading on Friday.

Perry Ellis International, Inc. designs, sources, markets, and licenses apparel products. Currently, there are 3 analysts who rate Perry Ellis International a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PERY - FREE

TheStreet Quant Ratings

rates Perry Ellis International as a

hold

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full

Perry Ellis International Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Usana Health (USNA) - FREE Research Report

Gull Global Ltd, who is 10% Owner at Usana Health, sold 10,000 shares at $118.96 on July 15, 2016. Following this transaction, the 10% Owner owned 6.3 million shares meaning that the stake was reduced by 0.16% with the 10,000-share transaction.

The shares most recently traded at $124.07, up $5.11, or 4.12% since the insider transaction. Historical insider transactions for Usana Health go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 30,000
  • 24-Week # shares sold: 60,000

The average volume for Usana Health has been 101,200 shares per day over the past 30 days. Usana Health has a market cap of $1.5 billion and is part of the health care sector and drugs industry. Shares are down 2.18% year-to-date as of the close of trading on Friday.

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company has a P/E ratio of 23.1. Currently, there are no analysts who rate Usana Health a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on USNA - FREE

TheStreet Quant Ratings

rates Usana Health as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and impressive record of earnings per share growth. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Usana Health Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Monotype Imaging Holdings (TYPE) - FREE Research Report

Martin Steven R, who is Exec VP, Chief Innovation Off. at Monotype Imaging Holdings, sold 2,000 shares at $25.12 on July 15, 2016. Following this transaction, the Exec VP, Chief Innovation Off. owned 81,883 shares meaning that the stake was reduced by 2.38% with the 2,000-share transaction.

The shares most recently traded at $24.94, down $0.18, or 0.72% since the insider transaction. Historical insider transactions for Monotype Imaging Holdings go as follows:

  • 4-Week # shares sold: 9,052
  • 12-Week # shares sold: 12,982
  • 24-Week # shares sold: 21,734

The average volume for Monotype Imaging Holdings has been 150,700 shares per day over the past 30 days. Monotype Imaging Holdings has a market cap of $1.0 billion and is part of the technology sector and computer software & services industry. Shares are up 5.41% year-to-date as of the close of trading on Friday.

Monotype Imaging Holdings Inc. develops, markets, and licenses technologies and fonts in the United States, the United Kingdom, Germany, Japan, and rest of Asia. The stock currently has a dividend yield of 1.75%. The company has a P/E ratio of 41.9. Currently, there are 3 analysts who rate Monotype Imaging Holdings a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TYPE - FREE

TheStreet Quant Ratings

rates Monotype Imaging Holdings as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full

Monotype Imaging Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.